Sbir topic 081: adjuvant development for vaccines against infectious or immune-mediated diseases
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93020C00041
- Awardee
-
Celdara Medical, LLC UEI MMVKQXZUBMQ7
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,977
Award facts
- Opportunity
-
- A solicitation of the national institutes of health (NIH) and the centers for disease control and prevention (CDC) for small business innovation research (SBIR) contract proposals Solicitation · PHS20201 · Posted Jun 21, 2019
- Contract value 100% obligated
- $599,977.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 12 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Lebanon, NH 03766, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $599,977 |
About this award
This definitive contract was awarded by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to Celdara Medical of Lebanon, New Hampshire. With a value of $599,977, the firm fixed price contract supports research under Solicitation Number NIH-CDC-SBIR-2019 in adjuvant development for vaccines against infectious or immune-mediated diseases. Specifically, the prime contractor will conduct work requested under Topic 081 of the solicitation, which sought small business proposals for research and development in areas including alternatives to cell culture materials, cancer immunotherapy manufacturing, senolytic agents for cancer treatment, and environmental health technologies among others. The period of performance is September 1, 2020 through February 28, 2023. This award was made under the Small Business Innovation Research program to stimulate technological innovation through the investment of federal research funds in small businesses.
Quick answers
Who was awarded contract 75N93020C00041?
75N93020C00041 was awarded to Celdara Medical, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2020.
How much is contract 75N93020C00041 worth?
The government has obligated $599,977 on 75N93020C00041.
Was contract 75N93020C00041 competed?
The extent of competition for 75N93020C00041 was full and open competition. The government received 12 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award